The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene
Open accessAbstract
Pain is a complex human trait. It is likely that the interaction of multiple genes, each with a small individual effect, along with the effect of environmental factors, influences the clinical efficacy of opioids rather than a single gene alone. Polymorphisms in genes coding for the mu-opioid receptor (A118G) and catechol-O-methyl transferase (Val158Met) may be important modulators of opioid efficacy. We assessed joint effects of the OPRM1 and COMT genes in predicting morphine dose for cancer pain relief. We used genotype and clinical data from a pharmacokinetic study of morphine in 207 inpatients treated with stable morphine dose for at least 3 days by Palliative Medicine Specialists. Results showed significant variation in morphine dose requirement by genotype groups: carriers of COMT Val/Val and Val/Met genotype required 63% and 23%, respectively, higher morphine dose compared to carriers of Met/Met genotype (p=0.02). Carriers of OPRM1 GG genotype required 93% higher morphine dose compared to carriers of AA genotypes (p=0.012). When we explored for joint effects, we found that carriers of the OPRM1 AA and COMT Met/Met genotype required the lowest morphine dose to achieve pain relief (87 mg/24 h; 95%CI=57,116) and those with neither Met/Met nor AA genotype needed the highest morphine dose (147 mg/24 h; 95%CI=100,180). The significant joint effects for the Met/Met and AA genotypes (p<0.012) persisted, even after controlling for demographic and clinical variables in the multivariable analyses. Future studies are needed to further characterize the joint effects of multiple genes, along with demographic and clinical variables, in predicting opioid dose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788 · cited 2×
“…et al., 1998; Befort et al., 2001; Wang et al., 2001; Lotsch et al., 2002; Klepstad et al., 2004; Fillingim et al., 2005; Lotsch and Geisslinger, 2006b) and COMT (Lachman et al., 1996; Zubieta et al., 2003; Shield et al., 2004; Rakvag et al., 2005) may be important modulators of opioid efficacy.”
BackgroundDiatchenko, L., Slade, G. D., Nackley, A. G., Bhalang, K., Sigurdsson, A., Belfer, I., Goldman, D., Xu, K., Shabalina, S. A., Shagin, D., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi013 · Cited by 1,280
COMT val 158 met Genotype Affects µ-Opioid Neurotransmitter Responses to a Pain Stressor
Zubieta, J.-K., Heitzeg, M. M., Smith, Y. R., Bueller, J. A., Xu, K., Xu, Y., Koeppe, R. A., Stohler, C. S., & Goldman, D. (2003) · Science · doi:10.1126/science.1078546 · Cited by 1,125
Molecular mechanisms of drug addiction
Nestler, E. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.031 · Cited by 1,108
Bond, C., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,074
Mor, V., Laliberte, L., Morris, J. N., & Wiemann, M. (1984) · Cancer · doi:10.1002/1097-0142(19840501)53:9<2002::aid-cncr2820530933>3.0.co;2-w · Cited by 1,067
Evaluation of patients with advanced cancer using the karnofsky performance status
Yates, J. W., Chalmer, B., & McKegney, F. P. (1980) · Cancer · doi:10.1002/1097-0142(19800415)45:8<2220::aid-cncr2820450835>3.0.co;2-q · Cited by 898
Comparison of Stopping Rules in Forward “Stepwise” Regression
Bendel, R. B., & Afifi, A. A. (1977) · Journal of the American Statistical Association · doi:10.1080/01621459.1977.10479905 · Cited by 885
The genetic mediation of individual differences in sensitivity to pain and its inhibition
Mogil, J. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7744 · Cited by 434
Kim, H., Neubert, J. K., San Miguel, A., Xu, K., Krishnaraju, R. K., Iadarola, M. J., Goldman, D., & Dionne, R. A. (2004) · Pain · doi:10.1016/j.pain.2004.02.027 · Cited by 428
Cited by
Pain and Stress in a Systems Perspective: Reciprocal Neural, Endocrine, and Immune Interactions
Chapman, C. R., Tuckett, R. P., & Song, C. W. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.006 · Cited by 541
Way, B. M., Taylor, S. E., & Eisenberger, N. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812612106 · Cited by 264
MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions
Andersen, H. H., Duroux, M., & Gazerani, P. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.003 · Cited by 175
Metadata
- Authors
- Reyes-Gibby, C. C., Shete, S., Rakvåg, T., Bhat, S. V., Skorpen, F., Bruera, E., Kaasa, S., & Klepstad, P.
- Venue
- Pain
- Published
- 2007-07
- Volume
- 130
- Issue
- 1
- Pages
- 25-30
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2083655489
- Cited by
- 313
- References
- 46
- FWCI
- 20.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. https://app.cochat.ai/papers/10.1016/j.pain.2006.10.023
- The paper
- Reyes-Gibby, C. C., Shete, S., Rakvåg, T., Bhat, S. V., Skorpen, F., Bruera, E., Kaasa, S., & Klepstad, P. (2007). Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain. https://doi.org/10.1016/j.pain.2006.10.023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
